Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Alabama at Birmingham
About this trial
The purpose of the study is to describe Hemophagocytic lymphohistiocytosis (HLH) in patients with lymphoma to identify possible therapeutic strategies to improve overall survival of the patients with lymphoma associated hemophagocytic lymphohistiocytosis.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients developing HLH> 1 month after lymphoma diagnosis (for aggressive lymphomas)
Patients with incomplete treatment and response documentation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov